XIST
SELEC
Market cap931mUSD
Nov 12, Last price
74.00TRY
Name
Selcuk Ecza Deposu Ticaret ve Sanayi AS
Chart & performance
P/E
—
P/S
0.27
EPS
—
Div yield, %
0.34%
Shrs. gr., 5y
—
Rev. gr., 5y
52.25%
Revenues
172.01b
+33.74%
Net income
-380m
L
CFO
-344m
L-96.08%
Dividend
Apr 17, 20260.44 TRY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. operates as a crucial intermediary within the pharmaceutical supply chain, overseeing the distribution of medicinal products from manufacturers to hospitals and pharmacies. In addition to this core function, the company manages its own dedicated pharmaceutical storage facility. Established in 1958, its principal operations are based in Istanbul, Turkey. The organization is ultimately controlled as a subsidiary of Selçuk Ecza Holding A.S.
Key people
Asli Gunel
Investor Relations Director
Ibrahim Haluk Ogutcu
Member of the Board of Directors, Member of the Management Board, Assistant General Manager · since 2003
Nazim Karpuzcu
Non-Executive Member of the Board
Resit Keskin
Independent Member of the Board
Headquarters & legal address
Altunizade Mah. Kuşbakışı Cad. Nakkaştepe No:37 Üsküdar
ISTANBUL 34398
TR
ISTANBUL 34398
TR
Valuation
Title TRY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||